New data show the efficacy of Equetro in patients with Bipolar I Disorder
Thu, 26 May 2005 05:00 AM EST
... Shire Pharmaceuticals Group announced today that EQUETROTM (carbamazepine extended-release capsules) are effective in significantly reducing the manic symptoms in patients with Bipolar I Disorder previously taking valproate or lithium, according to a pooled analysis of two phase 3 trials, one of two posters about carbamazepine extended-release capsules presented today at a major medical meeting in Atlanta, Ga... click link for more info. ...
Related Topics
- Bipolar Disorder
- Data & Statistics
- Data Analysis
- National Data
- Adrenal Gland Disorders
- Borderline Personality Disorder
- Seizure Disorder
- Oxcarbazepine
- Sleep Disorders
- Aripiprazole
- Genetic Disorders
- Blood Disorders
- Communication Disorders
- Dissociative Disorders
- Language Disorders
- Mining
- Seasonal Affective Disorder
- Autoimmune Disorders
- Topiramate
- Ziprasidone

Not Signed In -


